Molbio Diagnostics Limited has fixed the price band for its initial public offering at ₹768 to ₹807 per equity share, setting the stage for its debut on Indian stock exchanges.
The company, a key player in the Indian diagnostics sector, will open its subscription window on August 10, closing three days later on August 12.
Anchor investor allocations are scheduled for August 7, providing an early signal of institutional demand before the public offering begins.
The pricing places Molbio Diagnostics in a higher valuation bracket compared to recent Indian IPOs, reflecting the company's established market position in diagnostic services.
The face value of each equity share is Re 1, with the issue size and minimum lot details to be confirmed in the final prospectus.
Investors will have a three-day window to subscribe, with the allotment and listing dates to be announced following the closure of the book.